Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Antibody engineering is crucial for developing targeted therapeutics and diagnostics.
• Single-chain variable fragments (scFv) offer advantages in antibody design due to their smaller size and modularity.
• Optimizing the binding affinity and specificity of scFvs is essential for their clinical utility.

Purpose of the Study:

• To engineer and characterize novel single-chain variable fragment (scFv) antibodies with enhanced binding properties.
• To evaluate the specificity and affinity of the developed scFvs against target antigens.
• To assess the potential of these engineered scFvs for diagnostic applications.

Main Methods:

• Antibody gene shuffling and display technologies were employed for scFv library construction.
• Surface plasmon resonance (SPR) was used to determine binding kinetics (k_a, k_d) and affinity (K_D).
• Fluorescence-activated cell sorting (FACS) was utilized for screening and validation of scFv binding.

Main Results:

• Engineered scFvs exhibited significantly improved association rates (k_a) and dissociation constants (K_D) compared to wild-type.
• Specificity profiling confirmed high selectivity for the intended target antigen, with minimal cross-reactivity.
• SPR analysis revealed nanomolar affinity for the lead scFv candidates.

Conclusions:

• Novel scFv antibodies with superior binding kinetics and specificity have been successfully engineered.
• The developed scFvs hold promise for sensitive and specific detection of target biomarkers.
• This work contributes to the advancement of antibody-based tools for research and diagnostics.